ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Nevro Corp

Nevro Corp (NVRO)

4.56
0.32
( 7.55% )
Updated: 11:31:12

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
4.56
Bid
-
Ask
-
Volume
309,844
4.216 Day's Range 4.56
3.165 52 Week Range 19.47
Market Cap
Previous Close
4.24
Open
4.26
Last Trade
6
@
4.56
Last Trade Time
11:31:12
Financial Volume
$ 1,361,555
VWAP
4.3943
Average Volume (3m)
596,375
Shares Outstanding
37,471,622
Dividend Yield
-
PE Ratio
-1.74
Earnings Per Share (EPS)
-2.46
Revenue
425.17M
Net Profit
-92.21M

About Nevro Corp

Nevro Corp is a medical device company. Its key product is the Senza spinal cord stimulation system, a neuromodulation platform for the treatment of chronic pain. Senza generates electrical impulses to relieve pain. The system is implanted by physicians and controlled by patients. It consists of lea... Nevro Corp is a medical device company. Its key product is the Senza spinal cord stimulation system, a neuromodulation platform for the treatment of chronic pain. Senza generates electrical impulses to relieve pain. The system is implanted by physicians and controlled by patients. It consists of leads, a trial stimulator, an implantable pulse generator, surgical tools, a clinician laptop programmer, a patient remote control, and a mobile charger. Nevro generates the majority of its revenue in the United States. It also receives nearly half of its revenue from Australia, the United Kingdom, and Germany. Show more

Sector
Surgical,med Instr,apparatus
Industry
Surgical,med Instr,apparatus
Website
Headquarters
Wilmington, Delaware, USA
Founded
-
Nevro Corp is listed in the Surgical,med Instr,apparatus sector of the New York Stock Exchange with ticker NVRO. The last closing price for Nevro was $4.24. Over the last year, Nevro shares have traded in a share price range of $ 3.165 to $ 19.47.

Nevro currently has 37,471,622 shares outstanding. The market capitalization of Nevro is $158.88 million. Nevro has a price to earnings ratio (PE ratio) of -1.74.

NVRO Latest News

Nevro Announces Preliminary Fourth-Quarter and Full-Year 2024 Revenue Results

Nevro Announces Preliminary Fourth-Quarter and Full-Year 2024 Revenue Results PR Newswire REDWOOD CITY, Calif., Jan. 13, 2025 Cash, Cash Equivalents and Short-Term Investments...

Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08

Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08 PR Newswire REDWOOD CITY, Calif., Dec. 17, 2024 REDWOOD CITY, Calif., Dec. 17, 2024 /PRNewswire/ -- Nevro Corp. (NYSE:...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
11.1734.51327433633.394.5653.16510581283.92060173CS
40.7820.63492063493.784.5653.1655811923.80490726CS
12-0.35-7.12830957234.916.853.1655963754.42017877CS
26-5.08-52.69709543579.6410.373.1655979975.38632298CS
52-13.7-75.027382256318.2619.473.1655582008.62731352CS
156-86.43-94.988460270490.9990.993.16556736228.63992942CS
260-114.58-96.1725700856119.14188.143.16551762263.58534243CS

NVRO - Frequently Asked Questions (FAQ)

What is the current Nevro share price?
The current share price of Nevro is $ 4.56
How many Nevro shares are in issue?
Nevro has 37,471,622 shares in issue
What is the market cap of Nevro?
The market capitalisation of Nevro is USD 158.88M
What is the 1 year trading range for Nevro share price?
Nevro has traded in the range of $ 3.165 to $ 19.47 during the past year
What is the PE ratio of Nevro?
The price to earnings ratio of Nevro is -1.74
What is the cash to sales ratio of Nevro?
The cash to sales ratio of Nevro is 0.38
What is the reporting currency for Nevro?
Nevro reports financial results in USD
What is the latest annual turnover for Nevro?
The latest annual turnover of Nevro is USD 425.17M
What is the latest annual profit for Nevro?
The latest annual profit of Nevro is USD -92.21M
What is the registered address of Nevro?
The registered address for Nevro is CORPORATION TRUST CENTER, 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801
What is the Nevro website address?
The website address for Nevro is www.nevro.com
Which industry sector does Nevro operate in?
Nevro operates in the SURGICAL,MED INSTR,APPARATUS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
SPIRSpire Global Inc
$ 16.1779
(17.06%)
766.74k
SLQTSelectQuote Inc
$ 4.355
(12.82%)
843.32k
MYTEMYT Netherlands Parent BV
$ 8.49
(11.42%)
508.76k
BBAIBigBear ai Holdings Inc
$ 3.76
(10.91%)
31.39M
ZVIAZevia PBC
$ 4.835
(9.64%)
738.62k
NOMNuveen Missouri Quality Municipal Income Fund
$ 4.52
(-59.97%)
311
EVTLVertical Aerospace Ltd
$ 9.2513
(-11.56%)
87.25k
NOTEFiscaNote Holdings Inc
$ 1.2492
(-7.47%)
1.25M
BORRBorr Drilling Limited
$ 3.54
(-7.33%)
3.29M
ALURAllurion Technologies Inc
$ 3.3328
(-6.64%)
21.7k
VALEVale SA
$ 8.685
(-0.86%)
114.39M
QBTSD Wave Quantum Inc
$ 5.86
(1.21%)
79.75M
BBAIBigBear ai Holdings Inc
$ 3.76
(10.91%)
31.39M
IONQIonQ Inc
$ 38.315
(-2.73%)
26.3M
TSMTaiwan Semiconductor Manufacturing Co Ltd
$ 218.11
(5.47%)
24.74M

NVRO Discussion

View Posts
TrendTrade2016 TrendTrade2016 40 minutes ago
NVRO STRONG IN A BAD MARKET
👍️0
TrendTrade2016 TrendTrade2016 22 hours ago
NVRO STRONG INTO 2025
👍️0
TrendTrade2016 TrendTrade2016 3 days ago
NVRO MONSTER
👍️0
TrendTrade2016 TrendTrade2016 3 days ago
NVRO BIO BEAST TAKING OFF
👍️0
whytestocks whytestocks 5 years ago
News: $NVRO Here's Why Nevro Stock Bounded Higher on Thursday

Shares of Nevro   (NYSE: NVRO) , a medical device company with a focus on pain management, are soaring in response to a positive third-quarter earnings report. The company reported earnings and revenue that blew past analyst expectations, and raised guidance for the rest of 2019. As a...

Find out more NVRO - Here's Why Nevro Stock Bounded Higher on Thursday
👍️0
joseytheoutlawwales joseytheoutlawwales 5 years ago
New system with both lower frequency ranges and combination therapies, in addition to HF10 (10k Hz) ranges, and brand new patient peripherals (ie, remote, charger, etc) should be out in November I’m told.

Should be interesting.
👍️0
whytestocks whytestocks 6 years ago
News: $NVRO Nevro to Highlight Substantial Body of Clinical Evidence Supporting Expanded Applications and Unique Capabilities of HF10 Therapy at the 14th International Neuromodulation Society World Congress

SYDNEY , May 26, 2019 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced a series of data presentations supporting the use of the Company's HF10Ȓ...

In case you are interested https://marketwirenews.com/news-releases/nevro-to-highlight-substantial-body-of-clinical-evidence-supporting-expanded-applications-and-unique-capabilities-of-hf10-therapy-at-the-14th-international-neuromodulation-society-world-congress-8248992.html
👍️0
stocktrademan stocktrademan 6 years ago
NVRO buy 61.44



normal chart







log chart






👍️0
KOmani KOmani 7 years ago
Down 14% on no news at all ....

Perhaps a little overdone?
👍️0
jimmybob jimmybob 8 years ago
$NVRO now up 49.3% YTD,closing at another all-time high today,and hitting all-time highs intra-day.. story not over… http://www.optionmillionaires.com/bull-case-nevro-nvro-update/
👍️0
jimmybob jimmybob 8 years ago
The Bull Case on Nevro ( $NVRO ) - Update : http://www.optionmillionaires.com/bull-case-nevro-nvro-update/ $MEDT $STJ $BSX $NURO $ETRM
👍️0
BudFoxWallStreet BudFoxWallStreet 8 years ago
Nevro's Revenue Surges, Lower Than Expected Loss |

https://www.medtechy.com/the-ticker/articles/2016/nevros-revenue-surges-lower-than-expected-loss

👍️0
jimmybob jimmybob 8 years ago
Snapshot on why I have/continue to love $NVRO (CC still going w/ speechless analysts) - http://www.optionmillionaires.com/bull-case-nevro-nvro/

👍️0
jimmybob jimmybob 9 years ago
One of the best growth stories out there, $NVRO revenue up 114% in ’15 looking for 137%+ in ’16

👍️0
jimmybob jimmybob 9 years ago
$NVRO - strong support around $65 , like for new all-time highs before Q1 earnings in May

👍️0
jimmybob jimmybob 9 years ago
Love the breakout on $NVRO friday.. $70+ next

👍️0
BudFoxWallStreet BudFoxWallStreet 9 years ago
Here is Nevro's JP Morgan presentation. They are also presenting at Leerink tomorrow but it is probably the same presentation.

https://www.medtechy.com/boards/companies/nevro/3825

👍️0
jimmybob jimmybob 9 years ago
Key theme from $NVRO @ #JPM16 : ’Expanding Market opportunities’ outside of $1.5 addressable market where its already taking sizable share
👍️0
RealGenius RealGenius 9 years ago
No way 1 billion MC justified here, when not even profitable.
👍️0
quaerere quaerere 9 years ago
Today Nevro submitted and posted a link to their preliminary response to the patent trial and appeals board with reference to the Boston Scientific Corporation challenge to the key Nevro patent.
See http://www.nevro.com/press-release/?r=US&prid=5aa76c3f-164d-4b00-8def-f9ad36ba33b2. I personally, though not a lawyer, was impressed by the strength of the rebuttal.
On another note, I have heard that the first few patients in my state that have received the preliminary trial for effectiveness of the Senza have faired well, and are going to move on to permanent implants. A number of advisory services have not been favorably viewing Nevro, but IMO that is because they are looking at past performance and not considering the game change that FDA approval represents. Others that look at the whole picture, such as Zacks, are very high on NVRO (Rank 1).
Long on NVRO, and added on the recent dip. The sparseness of contributions to this board is an indication that the stock is flying under the radar. I was clued in when the Senza was recommended for my spouse.
👍️0
stocktrademan stocktrademan 10 years ago
$NVRO recent news/filings

bullish

basic chart ## source: stockcharts.com



basic chart ## source: stockscores.com

[img]http://charts.stockscores.com/chart.asp?

TickerSymbol=NVRO&TimeRange=400&Interval=d&Volume=1&ChartType=CandleStick&ChartWidth=830&ChartHeight=500&LogSc

ale=None&Band=BB&avgType1=EMA&movAvg1=50&indicator1=MACD&candles=redgreen[/img]

big daily chart ## source: stockcharts.com

[img]stockcharts.com/c-sc/sc?chart=NVRO,uu[e,a]dhclyiay[uu][pb5!b10!b50!b100!b200!d20,2!h.02,.20!f][vb5!b20]

[iut!lv8!lk9!LE12,26,9!ll14!la6,13,5!la8,17,9!la12,26,9!uc14!ub14!ub6!lo!lp7,3!lh9,3!LI14,3!lxa!ld8!lq!lg14!

lf14][j20444984,y]&r=3555b[/img]

big weekly chart ## source: stockcharts.com

[img]stockcharts.com/c-sc/sc?chart=NVRO,uu[e,a]whclyiay[uu][pb5!b10!b50!b100!b200!d20,2!h.02,.20!f][vb5!b20]

[iut!lv8!lk9!LE12,26,9!ll14!la6,13,5!la8,17,9!la12,26,9!uc14!ub14!ub6!lo!lp7,3!lh9,3!LI14,3!lxa!ld8!lq!lg14!

lf14][j20444984,y]&r=3555b[/img]

$NVRO DD Notes ~ http://www.ddnotesmaker.com/NVRO

## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=NVRO+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=NVRO+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=NVRO+Industry

## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/NVRO/news - http://finance.yahoo.com/q/h?s=NVRO

+Headlines

## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/NVRO/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/NVRO/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=NVRO+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/NVRO
DTCC (dtcc.com): http://search2.dtcc.com/?q=Apple%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Apple%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Apple%2C

+Inc.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.apple.com/pr
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.apple.com/pr#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.apple.com/pr

## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/NVRO
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?

action=getcompany&CIK=0000320193&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/NVRO/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/NVRO/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=NVRO&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=NVRO
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/NVRO/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=NVRO+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=NVRO+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=NVRO
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=NVRO
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=NVRO+NVROh+Flow&annual

## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/NVRO/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=NVRO+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/NVRO.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=NVRO
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/NVRO/insider-transactions

## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/NVRO
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/NVRO
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/NVRO:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=NVRO
Bussinessweek (businessweek.com):

http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=NVRO
StockTwits (stocktwits.com): http://stocktwits.com/symbol/NVRO

$NVRO DD Notes ~ http://www.ddnotesmaker.com/NVRO
👍️0
uptowndw uptowndw 10 years ago
WTF???? huge jump but on only 2k shares how is this possible?????
👍️0
Penny Roger$ Penny Roger$ 10 years ago
My back hurts. Congrats on IPO $NRVO!

https://www.google.com/finance?q=NVRO

Nevro Corp. is a medical device company focused on developing solutions in the neuromodulation space. The Company provides pain relief to the customers suffering from low back pain and types of chronic pains. The Company’s High-frequency spinal cord stimulation (SCS) system, the HF10 SCS, is a spinal cord simulation therapy, which provides electric pulses at a rate of approximately 10,000 Hz for spinal cord stimulation in the treatment of chronic back and leg pain. The electrical pulses are conveyed by small electrodes placed in the epidural space and connected to a battery-powered generator implanted under the skin. The Nevro Senza SCS system is available in Europe and Australia. It is undergoing a pivotal clinical trial, which is intended to collect data to support an application for a Nevro Senza implantable spinal cord stimulation system. The Company’s SENZA-RCT study is intended to evaluate the safety and effectiveness of the Senza SCS system.
👍️0